Thursday, November 2, 2023

Meril Receives Prestigious WIPO National Award For Innovation In Medical Devices

Meril Life Sciences Pvt Ltd, a global Indian medical devices company has been awarded the World Intellectual Property Organization’s (WIPO) National Award for Inventors. The award, presented by the WIPO and the Indian Patent Office, is offered to organisations for inventions which are considered to be significant contributions to the economic and technological development of their countries. The award is a recognition of Meril’s notable work towards securing patents and commercialising them to boost manufacturing in India.

WIPO Director General, Mr. Daren Tang, underscored Meril's dedication to devising innovative medical products that address previously unmet clinical needs.

Mr. Vivek Shah, CEO, Meril group of companies said, "Receiving the WIPO National Award is an honour for us. It acknowledges our commitment to excellence and our relentless pursuit of innovative solutions that make a tangible difference in healthcare. At Meril, we always strive to push the boundaries of innovation in the medical device industry,"

The WIPO National Award for Inventors was launched in 1979 to stimulate inventive and innovative activity around the world and to recognize the contribution of inventors to national wealth and development.

About Meril:

Meril is a leading global medical device company based out of India. It has been instrumental in making India a leader in the global medical devices industry. Through its dedication towards innovation, quality, the company has revolutionised healthcare in India and made a significant impact globally. The company leverages global collaborations and cutting-edge technology, while emphasising on quality control and compliance with global regulations and contributing to a robust research and development ecosystem. Meril has successfully positioned India as a hub for medical device innovation and manufacturing, enhancing the country’s credibility and visibility on the global stage.

No comments:

Total Pageviews